{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028464","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2026-06-12T20:32:13+00:00","discovered_at":"2026-06-12T20:33:00.721075+00:00","generated_at":"2026-06-12T20:53:17.264524+00:00","sec_items":["3.01","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Wellgistics Health gets Nasdaq equity-compliance extension to Oct 12, regains bid-price rule","bullets":["Nasdaq grants extension to Oct 12, 2026 to meet $2.5M min. stockholders' equity; current equity is $(12.4M).","To remedy, plans merger with DataVault AI and acquisition of patent portfolio + controlling Tollo Health stake.","Estimates post-transaction assets of $4B and stockholders' equity of ~$40M.","Regained compliance with Nasdaq $1.00 min bid price rule, effective June 9; bid closed >=$1.00 for 10 consecutive days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028464","json":"https://secwatch.observer/filing/0001493152-26-028464.json","markdown":"https://secwatch.observer/filing/0001493152-26-028464.md","text":"https://secwatch.observer/filing/0001493152-26-028464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226028464/0001493152-26-028464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226028464/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:53:17.264524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da12bfe5368ba31b1518c8c961ba8a10fd9ca053","claim":"Wellgistics Health, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"ng Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) (the “Rule”), which requires that a listed company’s stockholders’ equity be at least $2,500,000 (the “Minimum Stockholders’ Equity Requirement”). As reported in its Form 10-K, as of December 31, 2025, the Company had a stockholders’ equity of $(12,447,801). The Company has taken affirmat","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226028464/0001493152-26-028464-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}